Proposed Registration Decision PRD2026-07, AQUABAC II XT Biological Larvicide, containing Bacillus thuringiensis subsp. Israelensis serotype H-14, strain BMP-144

Health Canada is proposing registration for the sale and use of AQUABAC II XT Biological Larvicide, containing Bacilllus thuringiensis subsp. israelensis serotype H-14, strain BMP-144, to control fungus gnats on greenhouse ornamentals (use-site category 6 – Greenhouse Non-Food). This evaluation was completed under the User Requested Minor Use Label Expansion program…
Read More